Department of Radiation Oncology, Technische Universität München, Klinikum rechts der Isar, Ismaninger Str. 22, 81675 Munich, Germany.
Phys Med Biol. 2011 Jun 7;56(11):3251-68. doi: 10.1088/0031-9155/56/11/006. Epub 2011 May 4.
The poor treatment prognosis for tumours with oxygen-deficient areas is usually attributed to the increased radioresistance of hypoxic cells. It can be expressed by the oxygen enhancement ratio (OER), which decreases with increasing linear energy transfer (LET) suggesting a potential clinical advantage of high-LET radiotherapy with heavy ion beams compared to low-LET photon or proton irradiation. The aim of this work is to review the experimental cell survival data from the literature and, based on them, to develop a simple OER model to estimate the clinical impact of OER variations. For this purpose, the standard linear-quadratic model and the Alper-Howard-Flanders model are used. According to our calculations for a carbon ion spread-out Bragg peak at clinically relevant intermediate oxygen levels (0.5-20 mmHg), the advantage of carbon ions might be relatively moderate, with OER values about 1%-15% smaller than for protons. Furthermore, the variations of OER with LET are much smaller in vivo than in vitro due to different oxygen partial pressures used in cell experiments or measured inside tumours. The proposed OER model is a simple tool to quantify the oxygen effect in a practical way and provides the possibility to do hypoxia-based biological optimization in treatment planning.
乏氧区域肿瘤的治疗预后较差,通常归因于乏氧细胞的放射抵抗性增加。可以用氧增强比(OER)来表示,随着线性能量传递(LET)的增加而降低,这表明与低 LET 的光子或质子照射相比,重离子束的高 LET 放射治疗具有潜在的临床优势。本工作的目的是综述文献中的实验细胞存活数据,并基于这些数据开发一个简单的 OER 模型来估计 OER 变化的临床影响。为此,使用了标准的线性二次模型和 Alper-Howard-Flanders 模型。根据我们对临床相关中间氧水平(0.5-20mmHg)下碳离子扩展布拉格峰的计算,碳离子的优势可能相对适中,与质子相比,OER 值约小 1%-15%。此外,由于细胞实验中或肿瘤内测量的氧分压不同,体内 OER 随 LET 的变化比体外小得多。所提出的 OER 模型是一种简单的工具,可以实际量化氧效应,并提供在治疗计划中进行基于缺氧的生物学优化的可能性。